Back to Search Start Over

ANALYSIS TREATMENT OUTCOME OF 46 REFRACTORY/RELAPSED PEDIATRIC MATURE B CELL LYMPHOMA PATIENTS‐MULTI‐CENTER EXPERIENCE FROM CHINA.

Authors :
Zhang, Y.
Huang, S.
Jin, L.
Yang, J.
Hu, B.
Zheng, C. M.
Zhai, W. X.
Wang, S. H.
Li, F.
Yang, X.
Liu, A.
Yuan, X.
Liu, W.
Zhang, L.
Wang, J.
Dai, Y.
Sun, L.
Zhou, C.
Gao, Z.
Source :
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p67-68, 2p
Publication Year :
2023

Abstract

Salvage treatment: 24 patients received second-line chemotherapy: 6 patients got a CR2, 6 patients quit to treatment due to SD/PD, 4 patients got a treatment related death, 8 patients died of PD/SD. ANALYSIS TREATMENT OUTCOME OF 46 REFRACTORY/RELAPSED PEDIATRIC MATURE B CELL LYMPHOMA PATIENTS-MULTI-CENTER EXPERIENCE FROM CHINA B Introduction: b Aim to find the efficacy treatment strategy for refractory/relapsed( I r i / I r i ) patients with pediatric mature B-cell lymphoma (MBL) by summarizing the treatment outcome of 46 patients from Chinese Children's Lymphoma Multi-center Cooperation Group (CNCL). [Extracted from the article]

Details

Language :
English
ISSN :
02780232
Volume :
41
Database :
Complementary Index
Journal :
Hematological Oncology
Publication Type :
Academic Journal
Accession number :
164231131
Full Text :
https://doi.org/10.1002/hon.3163_32